Market Price

59.39 

-1.06 -1.8%

as of Oct 22 '18

52 Week Range:

56.08 67.71


Stock Analyzer Tutorials

S2O Stock Analyzer - General Info

General Info


type: video (mp4); length: 3:30

Demonstrates how to use Stock Analyzer, shows how to analyze a stock and explains in detail "General Info" section of the Stock Analyzer result page.

S2O Stock Analyzer - Financial Statements

Financial Statements


type: video (mp4); length: 5:10

Explains information presented in the Financial Statements section of the S2O Stock Analyzer: financial statements charts, absolute values and growth rates.

S2O Stock Analyzer - Growth Grade and Financial Ratios

Growth Grade and Financial Ratios


type: video (mp4); length: 5:09

Demonstrates how to use Growth Grade & Financial Ratios section; shows the difference between historical and year-over-year Growth Grade on the real life example.

S2O Stock Analyzer - Value Price

Value Price


type: video (mp4); length: 6:03

Demonstrates how to use Value Price (intrinsic value) and the Graham Number, MOS (margin of safety) and IRT - Investment Recovery Time; explains 3 different projection models used to compute value price - pessimistic, moderate and optimistic.

S2O Stock Analyzer - Price Charts

Price Charts


type: video (mp4); length: 8:34

Demonstrates basic rules of how to read a candlestick chart, long and short term moving averages, stochastic, MACD and relative strength (RS) charts. Explains how bull or bear market condition is computed.

General Info

Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products worldwide. It operates in two segments, BD Medical and BD Life Sciences. The BD Medical segment offers syringes, pen needles, and other products for diabetes; needles, syringes, and intravenous catheters for medication delivery; prefilled IV flush syringes; regional anesthesia needles and trays; sharps disposal containers; closed-system transfer devices; skin antiseptic products; surgical and laparoscopic instrumentations; intravenous medication safety and infusion therapy delivery, and automated medication dispensing and supply management systems; medication inventory optimization and tracking systems; and prefillable drug delivery systems. The BD Life Sciences segment provides integrated systems for specimen collection; safety-engineered blood collection, automated blood culturing and tuberculosis culturing, and microorganism identification and drug susceptibility systems; molecular testing systems for infectious diseases and women's health; liquid-based cytology systems for cervical cancer screening; rapid diagnostic assays; microbiology laboratory automation and plated media products; fluorescence-activated cell sorters and analyzers; monoclonal antibodies and kits for performing cell analysis; reagent systems for life science research; molecular indexing and next-generation sequencing sample preparation for genomics research; clinical oncology, immunological, and transplantation diagnostic/monitoring reagents and analyzers; and cell culture media supplements for biopharmaceutical manufacturing. The company markets its products through independent distribution channels and sales representatives to healthcare institutions, life science researchers, clinical laboratories, pharmaceutical industry, and general public. Becton, Dickinson and Company was founded in 1897 and is based in Franklin Lakes, New Jersey.

Financial Statements

The charts below show selected Annual and Quarterly Financial Data.

The purpose of these charts is to discover long and short term change dynamics. When numbers are growing year after year in the annual statements chart, the business become stronger and stronger and this is a good sign.

Quarterly Data Chart can be used to do a short term analysis. It makes sense to pay attention to the quarterly dynamics and do not wait for the next yearly statement. We should be alerted if we see that quarterly numbers are going down.

You can check "Annual Financial Statements" and "Quarterly Financial Statements" sections for exact numbers and growth rates.

Annual Statements

On a charts below the Line shows absolute values and the Bar chart shows Year-Over-Year Growth Rate for selected financial statement item. A consistent GROWTH is generally considered necessary to fund future growth from within a business.
NOTE: Growth Rate is not provided if either the latest period or the year-ago period contains a net loss. (source: WSJ Digest of Earnings)
TIP! move your mouse pointer over bar or a circle on any chart below to see details.

Financial Statements

Income Statement



 

Cash Flow Statement



 

Balance Sheet



 

Liquidity Ratios

Current Ratio


 

Current Ratio measures the ability to meet short term obligations. Generally accepted standard is 2 (current assets should be 2 times or 200% of current liabilities).

Quick Ratio


 

Measures immediate liquidity or the cash available to cover immediate liabilities. A safe margin would be at least 1 (100%).

Financial Leverage


 

Defined as total assets divided by total shareholders' equity. The higher the ratio, the more debt a company uses in its capital structure.

Profitability Ratios

ROA


 

Return on Assets (ROA) measures the income (profit) that is generated by the use of the assets of the business.

ROE


 

Return on Equity (ROE) is a measure of profitability that calculates how many dollars of profit a company generates with each dollar of shareholders equity. ROE is sometimes called "return on net worth."

ROIC


 

The Return on Invested Capital (ROIC) measure gives a sense of how well a company is using its money to generate returns. Some investors use this figure as a final evaluation to determine whether or not to invest in a company.

Annual Statements

Item Name Sep '07 Sep '08 Sep '09 Sep '10 Sep '11 Sep '12 Sep '13 Sep '14 Sep '15 Sep '16 Sep '17
Earnings BIT 1,632.00
1,793.00
2,158.00
2,245.00
growth rate 9.9% 20.4% 4.0%
Avg.PE 9.19
17.44
growth rate 89.8%
ROA 12.58
14.79
14.31
13.90
12.66
10.74
11.00
9.64
3.54
3.72
3.25
growth rate 17.6% -3.3% -2.9% -8.9% -15.2% 2.4% -12.4% -63.3% 5.1% -12.6%
ROE 21.71
24.24
24.44
24.91
24.77
26.10
28.18
23.48
11.38
13.19
10.01
growth rate 11.7% 0.8% 1.9% -0.6% 5.4% 8.0% -16.7% -51.5% 15.9% -24.1%
ROIC 16.57
19.41
18.85
18.76
17.73
15.56
15.84
13.91
7.10
6.69
5.56
growth rate 17.1% -2.9% -0.5% -5.5% -12.2% 1.8% -12.2% -49.0% -5.8% -16.9%
Cur. Ratio 2.11
2.55
2.61
2.70
2.56
2.69
2.76
2.74
1.38
1.45
5.58
growth rate 20.9% 2.4% 3.5% -5.2% 5.1% 2.6% -0.7% -49.6% 5.1% 284.8%
Quick Ratio 1.19
1.49
1.75
1.76
1.53
1.73
1.81
1.76
0.72
0.80
4.78
growth rate 25.2% 17.5% 0.6% -13.1% 13.1% 4.6% -2.8% -59.1% 11.1% 497.5%
Leverage 1.68
1.60
1.81
1.78
2.16
2.75
2.41
2.46
3.74
3.35
2.91
growth rate -4.8% 13.1% -1.7% 21.4% 27.3% -12.4% 2.1% 52.0% -10.4% -13.1%
Balance Sheet Sep '07 Sep '08 Sep '09 Sep '10 Sep '11 Sep '12 Sep '13 Sep '14 Sep '15 Sep '16 Sep '17
Acct.Receivable 1,192.00
1,693.00
1,957.00
1,760.00
growth rate 42.0% 15.6% -10.1%
Acct.Payable 401.00
631.00
665.00
797.00
growth rate 57.4% 5.4% 19.9%
Cur.Assets 6,130.00
5,659.00
6,365.00
18,634.00
growth rate -7.7% 12.5% 192.8%
Total Assets 12,447.00
26,478.00
25,586.00
37,734.00
growth rate 112.7% -3.4% 47.5%
Cash 1,861.00
1,424.00
1,541.00
14,179.00
growth rate -23.5% 8.2% 820.1%
Inventory 1,495.00
1,959.00
1,719.00
1,818.00
growth rate 31.0% -12.3% 5.8%
Cur.Liabilities 2,235.00
4,381.00
4,400.00
3,342.00
growth rate 96.0% 0.4% -24.1%
Liabilities 7,394.00
19,314.00
17,953.00
24,786.00
growth rate 161.2% -7.1% 38.1%
LT Debt 3,768.00
11,370.00
10,550.00
18,667.00
growth rate 201.8% -7.2% 76.9%
Equity 5,053.00
7,164.00
7,633.00
12,946.00
growth rate 41.8% 6.6% 69.6%
Common Shares 333.00
333.00
333.00
347.00
growth rate 0.0% 0.0% 4.2%
Cash Flow Statement Sep '07 Sep '08 Sep '09 Sep '10 Sep '11 Sep '12 Sep '13 Sep '14 Sep '15 Sep '16 Sep '17
Capital Expenditures 592.00
596.00
693.00
727.00
growth rate 0.7% 16.3% 4.9%
Cash Dividends 421.00
485.00
562.00
677.00
growth rate 15.2% 15.9% 20.5%
Cash From OA 1,746.00
1,730.00
2,559.00
2,550.00
growth rate -0.9% 47.9% -0.4%
Sale Purchase of Stock 4,827.00
4,827.00
4,827.00
4,827.00
growth rate 0.0% 0.0% 0.0%
FCF 662.00
1,036.00
1,016.00
1,112.00
1,111.00
1,207.00
917.00
1,093.00
1,097.00
1,841.00
1,823.00
growth rate 56.5% -1.9% 9.5% -0.1% 8.6% -24.0% 19.2% 0.4% 67.8% -1.0%
Income Statement Sep '07 Sep '08 Sep '09 Sep '10 Sep '11 Sep '12 Sep '13 Sep '14 Sep '15 Sep '16 Sep '17
Sales 8,446.00
10,282.00
12,483.00
12,093.00
growth rate 21.7% 21.4% -3.1%
Op.Income 1,632.00
1,793.00
2,158.00
2,245.00
growth rate 9.9% 20.4% 4.0%
IBT 1,522.00
739.00
1,073.00
976.00
growth rate -51.5% 45.2% -9.0%
Net Income 1,185.00
695.00
976.00
1,100.00
growth rate -41.4% 40.4% 12.7%
Gross Profit 4,301.00
4,988.00
5,991.00
5,942.00
growth rate 16.0% 20.1% -0.8%
R&D 524.00
632.00
828.00
774.00
growth rate 20.6% 31.0% -6.5%

Quarterly Statements

Item Name Jun '17 Sep '17 Dec '17 Mar '18 Jun '18
Earnings BIT 598.00
562.00
584.00
708.00
714.00
growth rate -6.0% 3.9% 21.2% 0.9%
Balance Sheet Jun '17 Sep '17 Dec '17 Mar '18 Jun '18
Acct.Receivable 1,784.00
1,760.00
2,000.00
2,293.00
2,243.00
growth rate -1.4% 13.6% 14.7% -2.2%
Acct.Payable 2,820.00
797.00
4,193.00
4,224.00
growth rate -71.7% 426.1% 0.7%
Cur.Assets 18,213.00
18,634.00
7,542.00
7,512.00
7,525.00
growth rate 2.3% -59.5% -0.4% 0.2%
Total Assets 37,166.00
37,734.00
55,363.00
54,573.00
53,977.00
growth rate 1.5% 46.7% -1.4% -1.1%
Cash 13,852.00
14,179.00
1,124.00
1,251.00
1,384.00
growth rate 2.4% -92.1% 11.3% 10.6%
Inventory 1,829.00
1,818.00
2,966.00
2,544.00
2,562.00
growth rate -0.6% 63.2% -14.2% 0.7%
Cur.Liabilities 3,273.00
3,342.00
4,896.00
4,426.00
6,107.00
growth rate 2.1% 46.5% -9.6% 38.0%
Liabilities 24,579.00
24,786.00
34,116.00
33,421.00
32,620.00
growth rate 0.8% 37.6% -2.0% -2.4%
LT Debt 18,563.00
18,667.00
22,095.00
22,589.00
20,350.00
growth rate 0.6% 18.4% 2.2% -9.9%
Equity 12,585.00
12,946.00
21,245.00
21,150.00
21,355.00
growth rate 2.9% 64.1% -0.5% 1.0%
Common Shares 347.00
347.00
347.00
347.00
347.00
growth rate 0.0% 0.0% 0.0% 0.0%
Cash Flow Statement Jun '17 Sep '17 Dec '17 Mar '18 Jun '18
Capital Expenditures 195.00
260.00
178.00
213.00
197.00
growth rate 33.3% -31.5% 19.7% -7.5%
Cash Dividends 199.00
199.00
210.00
239.00
238.00
growth rate 0.0% 5.5% 13.8% -0.4%
Cash From OA 384.00
1,126.00
320.00
697.00
542.00
growth rate 193.2% -71.6% 117.8% -22.2%
Sale Purchase of Stock 4,827.00
growth rate
FCF 189.00
866.00
142.00
484.00
345.00
growth rate 358.2% -83.6% 240.9% -28.7%
Income Statement Jun '17 Sep '17 Dec '17 Mar '18 Jun '18
Sales 3,035.00
3,166.00
3,080.00
4,222.00
4,278.00
growth rate 4.3% -2.7% 37.1% 1.3%
Op.Income 598.00
562.00
584.00
708.00
714.00
growth rate -6.0% 3.9% 21.2% 0.9%
IBT -403.00
326.00
105.00
6.00
647.00
growth rate 100.0% -67.8% -94.3% 10,683.3%
Net Income -132.00
327.00
-136.00
-12.00
594.00
growth rate 100.0% -100.0% 0.0% 100.0%
Gross Profit 1,503.00
1,554.00
1,550.00
2,025.00
2,072.00
growth rate 3.4% -0.3% 30.7% 2.3%
R&D 186.00
220.00
192.00
260.00
277.00
growth rate 18.3% -12.7% 35.4% 6.5%

Growth Grade & Financial Ratios

All financial ratios below are calculated based on latest annual statements available and present the most up to date snapshot of a company finances.

Growth Grade

Historical Growth Grade:

C (58.97)

YOY Growth Grade:

D (47.76)

Click on buttons above for detailed yearly growth rates.

Market Ratios

Profitability Ratios

Liquidity Ratios

Efficiency Ratios

Value Price

PE and EPS

Historical Current Forward
PE 24.78 24.35
EPS / Growth 2.44

Value Price & Investment Recovery Time

Read more about Stock2Own value price in Stock Market: Fundamental Analysis.

Equity Growth Rate: 47.0%

Estimates Pessimistic Moderate Optimistic My Numbers
Rate of Return 15.0%
MOS Price % 50 %
Future EPS Growth 40.0% 47.0% 47.0%
Future PE 0.01 16.52 39.57
Future EPS 70.55 114.60 114.60
Value Price
MOS %
0.17
-99.7%
468.08
688.1%
1,120.96
1,787.5%
MOS Price 0.09 234.04 560.48
IRT 6.14 5.60 5.60

Graham Number:

NOTE: The Graham Number applies only to certain types of stocks in combination with a number of other criteria.

Read more about Graham Number in Stock Market: Fundamental Analysis.

Price Chart

The functionality you are trying to reach is available to registered users only.

Login to your account or Register Now if you are not registered yet. Registration is FREE and will take only a minute.

Risk / Reward Ratios

The functionality you are trying to reach is available to registered users only.

Login to your account or Register Now if you are not registered yet. Registration is FREE and will take only a minute.